FIELD: internal diseases.
SUBSTANCE: patient is administered diet including 0.3-0.5 g/kg/day animal for 10 days followed by increase to dose 0.8-1 g/kg/day during 1 month, after which 5% glucose solution is administered intravenously in dose 400-500 ml for 1 weak, lactulose in dose 60-90 ml divided into 2-3 intakes for 4 weeks, and probiotics over a 2-weak period 30 min before meal time. Simultaneously, L-ornithine-L-aspartate is given during 10 days in dose 30-40 g a day divided into 2-3 intakes followed by dose 5-7 g thrice a day during 10 days.
EFFECT: achieved involution of neurological and psychical manifestations of encephalopathy, reduced hepatic coma development incidence, and increased protein tolerance in patients.
4 cl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF TREATING INFLAMMATORY INTESTINAL DISEASES | 2011 |
|
RU2463055C2 |
METHOD OF TREATING NON-ALCOHOLIC FATTY LIVER DISEASE | 2011 |
|
RU2473342C1 |
DIFFERENTIAL DIAGNOSTIC TECHNIQUE FOR LIVER DISEASES OF VARIOUS AETIOLOGIES ACCOMPANIED WITH INTRAHEPATIC CHOLESTASIS | 2008 |
|
RU2386969C2 |
METHOD OF ULCERATIVE COLITIS AND CROHN'S DISEASE THERAPY | 2011 |
|
RU2460554C1 |
METHOD OF TREATING VARIX DILATATION OF ESOPHAGUS IN CASE OF PORTAL HYPERTENSION | 2010 |
|
RU2435591C1 |
DIFFERENTIAL DIAGNOSTIC TECHNIQUE OF CHRONIC HEPATITIS AND HEPATIC CIRRHOSIS OF ALCOHOLIC AETIOLOGY | 2011 |
|
RU2477482C1 |
METHOD OF TREATING METABOLIC SYNDROME | 2009 |
|
RU2398562C1 |
METHOD FOR PREDICTION OF PROGRESSION OF HEPATIC FAILURE IN INTRAHEPATIC CHOLESTASIS | 2008 |
|
RU2372619C1 |
DIFFERENTIAL DIAGNOSTIC TECHNIQUE FOR INTRAHEPATIC CHOLESTASIS | 2008 |
|
RU2386134C1 |
METHOD FOR PREDICTING PORTAL HYPERTENSION | 2004 |
|
RU2257841C1 |
Authors
Dates
2006-12-10—Published
2005-06-17—Filed